Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial - AFFINITY Trial Collaboration.
BACKGROUND: Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethni... (Source: SafetyLit)
Source: SafetyLit - July 27, 2020 Category: International Medicine & Public Health Tags: Falls Source Type: news
Serious shortage protocol (SSP) for fluoxetine - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules. This has been extended to Monday 10 August
Further information on the SSP can b (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 16, 2020 Category: Drugs & Pharmacology Source Type: news
Serious shortage protocol (SSP) for fluoxetine (England) - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 10mg tablets. This has been extended to Friday 11 September 2020.
Further information on the S (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 2, 2020 Category: Drugs & Pharmacology Source Type: news
Behavioral therapy and fluoxetine treatment in aggressive dogs: a case study - Odore R, Rendini D, Badino P, Gardini G, Cagnotti G, Meucci V, Intorre L, Bellino C, D'Angelo A.
Canine aggression is a major concern, affecting millions of people worldwide, and treatment can be challenging even for skilled veterinarians. Empiric use of fluoxetine is sometimes attempted, although few data regarding long-term effects in aggressive dog... (Source: SafetyLit)
Source: SafetyLit - May 18, 2020 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news
